Amneal Pharmaceuticals Inc (AMRX)

개요 뉴스 가격 이력 옵션 체인 토론 예측

Relative Volume:

Amneal Pharmaceuticals Inc Stock (AMRX) Company Profile

Amneal Pharmaceuticals Inc

Healthcare (1195)

908-947-3120

400 Crossing Boulevard, 3rd Floor, Bridgewater

@amnealpharma

최신 SEC 제출 서류

AMRX's Discussions on Twitter

AMRX을(를) 다른 주식과 비교

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
AMRX	8.32	2.59B	2.50B	-168.69M	124.24M	-0.02
ZTS	176.69	79.33B	9.15B	2.43B	2.31B	4.92
HLN	9.55	43.04B	14.26B	1.55B	0	0.3327
TAK	13.32	42.13B	30.27B	1.93B	3.45B	0.444
TEVA	17.07	19.29B	16.77B	-959.00M	1.37B	-2.00
VTRS	13.24	15.77B	15.24B	-646.50M	1.88B	1.53

Amneal Pharmaceuticals Inc Stock (AMRX) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2021-04-07	재개	RBC Capital Mkts	Sector Perform
2021-03-08	업그레이드	Goldman	Sell → Buy
2020-12-14	업그레이드	Barclays	Equal Weight → Overweight
2020-12-14	업그레이드	Guggenheim	Neutral → Buy
2020-07-27	개시	Goldman	Sell
2020-05-12	업그레이드	Guggenheim	Sell → Neutral
2019-12-12	다운그레이드	Raymond James	Outperform → Mkt Perform
2019-11-12	다운그레이드	JP Morgan	Neutral → Underweight
2019-11-07	다운그레이드	SVB Leerink	Outperform → Mkt Perform
2019-07-22	업그레이드	SVB Leerink	Mkt Perform → Outperform
2019-07-11	다운그레이드	RBC Capital Mkts	Outperform → Sector Perform
2019-07-08	업그레이드	Piper Jaffray	Neutral → Overweight
2019-06-11	개시	Barclays	Equal Weight
2019-05-21	업그레이드	Raymond James	Mkt Perform → Strong Buy
2019-03-20	개시	SunTrust	Buy
2019-03-08	다운그레이드	SVB Leerink	Outperform → Mkt Perform
2018-12-14	다운그레이드	Morgan Stanley	Overweight → Equal-Weight
2018-10-16	다운그레이드	SunTrust	Buy → Hold
2018-08-13	업그레이드	RBC Capital Mkts	Sector Perform → Outperform
2018-07-23	개시	Morgan Stanley	Overweight
2018-06-22	개시	B. Riley FBR, Inc.	Buy

Amneal Pharmaceuticals Inc 주식(AMRX)의 최신 뉴스

Amneal Pharmaceuticals Inc (AMRX) 재무 분석

Amneal Pharmaceuticals Inc (AMRX)

Amneal Pharmaceuticals Inc Stock (AMRX) Company Profile

AMRX을(를) 다른 주식과 비교

Amneal Pharmaceuticals Inc Stock (AMRX) Upgrades & Downgrades

Amneal Pharmaceuticals Inc 주식(AMRX)의 최신 뉴스

GSA Capital Partners LLP Sells 100,410 Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) - MarketBeat

Senior VP Of Amneal Pharmaceuticals Sold 76% Of Their Shares - Simply Wall St

Amneal Pharmaceuticals Q3 2024 Earnings Preview - MSN

AMNEAL PHARMACEUTICALS, INC. (AMRX) Hit a 52 Week High, Can the Run Continue? - MSN

Brokerages Set Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Price Target at $10.00 - MarketBeat

Phocas Financial Corp. Reduces Position in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) - MarketBeat

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Short Interest Down 16.3% in October - MarketBeat

Sandoz, Amneal Get Mixed Ruling in State Drug Price-Fixing Case - Bloomberg Law

Amneal Pharmaceuticals' SWOT analysis: generic drug maker's stock poised for growth - Investing.com

Amneal stock target gets a boost, overweight on strong Q3 results - Investing.com Canada

Amneal Pharmaceuticals (NASDAQ:AMRX) Hits New 1-Year High After Analyst Upgrade - MarketBeat

Piper Sandler Raises Amneal Pharmaceuticals (NASDAQ:AMRX) Price Target to $11.00 - MarketBeat

Revenues Working Against Amneal Pharmaceuticals, Inc.'s (NASDAQ:AMRX) Share Price - Simply Wall St

Amneal Pharmaceuticals Inc (AMRX) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada

Earnings call: Amneal Pharmaceuticals sees a 13% revenue surge in Q3 2024 - Investing.com

Amneal Pharmaceuticals (AMRX) Surpasses Q3 Earnings and Revenue Estimates - MSN

Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Q3 2024 Earnings Call Transcript - MSN

Nisa Investment Advisors LLC Sells 221,848 Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) - MarketBeat

Amneal Pharma A earnings beat by $0.03, revenue topped estimates - Investing.com Canada

Amneal Pharmaceuticals Reports Q3 2024 Financial Results - TipRanks

Amneal: Q3 Earnings Snapshot - The Washington Post

Amneal Reports Third Quarter 2024 Financial Results - BioSpace

Amneal (AMRX) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance

Generic Drug-Focused Amneal Beats Q3 Expectations, Reaffirms Annual Forecasts - Yahoo Finance UK

Amneal Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Amneal Pharmaceuticals (NASDAQ:AMRX) Updates FY 2024 Earnings Guidance - MarketBeat

Amneal Pharmaceuticals, Inc. Affirms Earnings Guidance for the Full Year 2024 - Marketscreener.com

Amneal Pharmaceuticals reports Q3 adjusted EPS 16c, consensus 13c - TipRanks

Amneal Pharmaceuticals Swings to 3Q Loss While Sales Climb - MarketWatch

Teva Fails To Convince Judge Inhaler Patents Require Drug - Law360

Amneal (AMRX) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures - MSN

Zacks.com featured highlights include Amneal Pharmaceuticals, Cronos Group, Carriage Services, Business First Bancshares and Amphenol - Yahoo Finance

Panel Discussion on ‘Next growth frontiers for India Pharma Inc' - Express Pharma

Earnings Preview: Amneal Pharmaceuticals (AMRX) Q3 Earnings Expected to Decline - MSN

Amneal Pharmaceuticals (AMRX) Scheduled to Post Earnings on Friday - MarketBeat

Amneal Pharmaceuticals (NASDAQ:AMRX) grows 3.0% this week, taking five-year gains to 211% - Yahoo Finance

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Short Interest Update - MarketBeat

Top Companies in the Phenazopyridine Market Set for Success - openPR

Assenagon Asset Management S.A. Purchases 642,065 Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) - MarketBeat

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

Amneal wins FDA approval for nerve agent pretreatment - Investing.com

Amneal wins FDA approval for nerve agent pretreatment By Investing.com - Investing.com Australia

Amneal Pharmaceuticals Gets FDA Approval for Pyridostigmine Bromide - MarketWatch

Amneal Receives U.S. FDA Approval of New Drug Application for Pyridostigmine Bromide Extended-Release Tablets - Business Wire

Amneal Pharmaceuticals (NASDAQ:AMRX) Sets New 12-Month HighWhat's Next? - MarketBeat

SG Americas Securities LLC Invests $531,000 in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) - MarketBeat

AMRX Stock Soars to 52-Week High, Reaching $8.94 - Investing.com

Cardiac Sarcoidosis Drugs Global Market Report |Hikma Pharmaceuticals PLC, Mylan N.V, Amneal Pharmaceuticals LLC, Mallin – IndiaPolitics.com - IndiaPolitics.com

Is Amneal Pharmaceuticals (AMRX) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Azathioprine Tablets Industry to Witness an Outstanding Growth by 2030 |Mylan, Zydus Pharmaceuticals, Amneal Pharmaceuti – IndiaPolitics.com - IndiaPolitics.com

Glycopyrrolate Injection Market Growth Report |Accord Healthcare, Advanz Pharma, American Regent, Amneal Pharmaceuticals – IndiaPolitics.com - IndiaPolitics.com

Amneal Pharmaceuticals Inc (AMRX) 재무 분석

매출

순이익

현금흐름

주당 순 이익

AMRX과 유사한 종목